Browse by Poster Presenter

Skip to main content

CTOS 2024 Main banner

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

O
Obeidin, Farres

Northwestern University, Feinberg School of Medicine, Department of Pathology
(P 179) PRIMARY MANAGEMENT OF LOCALIZED GASTROINTESTINAL STROMAL TUMORS WITH IMATINIB MONOTHERAPY: AN ALTERNATIVE TO RESECTION FOR PATIENTS PRECLUDED FROM SURGERY
Farres Obeidin
Favorite
(P 222) ANALYSIS OF THE CITN-13 SARCOMA ARM: PEMBROLIZUMAB AND INTERFERON GAMMA FOR SYNOVIAL SARCOMA AND MYXOID/ ROUND CELL LIPOSARCOMA
Farres Obeidin
Favorite
(P 235) INFILTRATION OF MUCOSAL-ASSOCIATED INVARIANT T CELLS (MAITS) INTO CHONDROSARCOMA TUMORS
Farres Obeidin
Favorite
Obergfell, Timo

SwissSarcomaNetwork
(P 204) IMPACT OF UNPéLANNED EXCISION ON THE SURVIVAL OF SARCOMA PATIENTS - A TARGET TRIAL EMULATION
Timo Obergfell
Favorite
Oberley, Matthew

Caris Life Sciences
(P 224) COMPREHENSIVE EVALUATION OF DNA DAMAGE RESPONSE PATHWAY ALTERATIONS AND ASSOCIATED IMMUNOTHERAPY-RESPONSE BIOMARKERS IN SARCOMAS
Matthew Oberley
Favorite
(P 246) THE GENOMIC AND IMMUNE LANDSCAPE OF LIPOSARCOMA AND ITS SUBTYPES
Matthew Oberley
Favorite
Oberoi, Sapna

CancerCare Manitoba
(P 293) CIC-REARRANGED SOFT TISSUE SARCOMAS: DOES CHEMOTHERAPY CHANGE NATURAL HISTORY AND PROGNOSIS? A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) STUDY
Sapna Oberoi
Favorite
Obrador-Hevia, Antonia

Fundació Institutd'InvestigacióSanitàriaIlles Balears –IdISBa
(P 13) GENOMIC PROFILING OF ADULT SOFT TISSUE SARCOMAS FROM A SINGLE CENTER EXPERIENCE
Antonia Obrador-Hevia
Favorite
(P 322) A NEW PLAYER IN SOFT TISSUE SARCOMA PROGRESSION: WNT5A IS A PROGNOSIS BIOMARKER AND A POTENTIAL ACTIONABLE TARGET
Antonia Obrador-Hevia
Favorite
O'Brien Cox, Anderson

Wake Forest
(P 430) QUANTITATIVE EMT GENE SCORES AT DIAGNOSIS INDICATE METASTASIS RISK AND SURVIVAL IN SYNOVIAL SARCOMA
Anderson O'Brien Cox
Favorite
Oda, Katsutoshi

The University of Tokyo, Division of Integrative Genomics
(P 103) BRAF MUTATIONS AND CONCURRENT ALTERATIONS IN PATIENTS WITH SOFT TISSUE SARCOMA
Katsutoshi Oda
Favorite
O'Donnell, edmond

university of california davis
(P 11) GENETIC AND EPIGENETIC CHARACTERIZATION OF SARCOMA STEM CELLS ACROSS SUBTYPES IDENTIFIES EZH2 AS A THERAPEUTIC TARGET
edmond O'Donnell
Favorite
Oesterheld, Javier

Atrium Health Levine Children's Hospital
(P 309) PHASE II TRIAL OF GEMCITABINE AND NAB-PACLITAXEL IN PATIENTS WITH RECURRENT SOFT TISSUE SARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Javier Oesterheld
Favorite
Ogura, Koichi

National Cancer Center Hospital
(P 249) TUMOR CELL DISAPPEARANCE FOLLOWING COVID-19 INFECTION IN A PATIENT WITH PLEOMORPHIC SPINDLE CELL SARCOMA: A CASE REPORT
Koichi Ogura
Favorite
Okada, Seiji

Osaka University
(P 324) BENZIMIDAZOLE DERIVATIVES AS NOVEL THERAPEUTIC AGENTS FOR INI1-DEFICIENT EPITHELIOID SARCOMA
Seiji Okada
Favorite
Okajima, Koichi

The University of Tokyo, Department of Orthopaedic Surgery
(P 57) CLINICAL GENOMIC PROFILING OF MALIGNANT GIANT CELL TUMOR OF BONE: A RETROSPECTIVE ANALYSIS USING A REAL-WORLD DATABASE
Koichi Okajima
Favorite
(P 103) BRAF MUTATIONS AND CONCURRENT ALTERATIONS IN PATIENTS WITH SOFT TISSUE SARCOMA
Koichi Okajima
Favorite
Okcu, M. Fatih

Baylor College of Medicine
(P 315) SALVAGE THERAPY EFFICACY IS MODIFIED BY RISK GROUP AT DIAGNOSIS IN PATIENTS WITH RELAPSED RHABDOMYOSARCOMA
M. Fatih Okcu
Favorite
Okimoto, Ross

University of California, San Francisco
(P 07) DIRECTLY TARGETING CIC-DUX4 FUSION AND MYC ONCOPROTEINS FOR UNDIFFERENTIATED ROUND CELL SARCOMAS
Ross Okimoto
Favorite
Okuno, Scott

Mayo Clinic
(P 120) USING AI PREDICTIONS FROM ECG TRACINGS TO PREDICT TOLERANCE TO ANTHRACYCLINE CHEMOTHERAPY IN SARCOMA
Scott Okuno
Favorite
(P 200) FRAILTY ASSESSMENT IN OLDER PATIENTS RECEIVING SARCOMA THERAPY
Scott Okuno
Favorite
(P 412) SARC044: A PHASE II TRIAL OF BEZUCLASTINIB IN COMBINATION WITH SUNITINIB IN PATIENTS WITH GIST WHO PROGRESSED ON SUNITINIB MONOTHERAPY
Scott Okuno
Favorite
Olino, Kelly

Yale University
(P 378) INGUINAL SARCOMAS - A RETROSPECTIVE ANALYSIS OF DIAGNOSIS, CLINICAL FEATURES, TREATMENT PATTERNS AND OUTCOMES (I-SARC): A STUDY BY TARPSWG
Kelly Olino
Favorite
Olsen, Mallery

Phoenix Children's Hospital
(P 305) LOCAL THERAPY APPROACHES IN RELAPSED PEDIATRIC SOFT TISSUE SARCOMA AND EWING SARCOMA PATIENTS: A SINGLE INSTITUTION SERIES
Mallery Olsen
Favorite
Olson, Aaron

Seattle Children's Research Institute
(P 330) EFFICACY OF NON-CARDIOTOXIC ANTHRACYCLINES IN EWING SARCOMA
Aaron Olson
Favorite
Olson, Adam

UPMC Hillman Cancer Center
(P 353) PREDICTING WOUND COMPLICATIONS FOLLOWING SOFT-TISSUE SARCOMA RESECTION AMONG PATIENTS WHO RECEIVED PRE-OPERATIVE RADIATION
Adam Olson
Favorite
O'Neill, Brianne

Inhibrx Biosciences, Inc
(P 95) THE TETRAVALENT DEATH RECEPTOR 5 AGONIST OZEKIBART (INBRX-109) IN PATIENTS WITH CHONDROSARCOMA: UPDATED RESULTS FROM A PHASE 1 STUDY
Brianne O'Neill
Favorite
O'Neill, Francis

The Jackson Laboratory for Genomic Medicine
(P 70) IDENTIFICATION OF NOVEL PROTEIN VARIANTS IN OSTEOSARCOMA TUMORS THROUGH LONG-READ RNA SEQUENCING
Francis O'Neill
Favorite
Ong, Johnny

Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore
(P 370) DEFYING NORMS - CENTRALIZATION OF SARCOMA CARE ON AN ISLAND NATION
Johnny Ong
Favorite
(P 375) FROM SAPLING TO SHADE: GROWTH OF A HIGH VOLUME ASIAN TERTIARY SARCOMA SPECIALISED CENTRE
Johnny Ong
Favorite
Onoe, Takuma

Hyogo Cancer Center
(P 168) EFFICACY OF LOW-DOSE IMATINIB IN A PATIENT WITH A GIST WITH KIT EXON 11 W557_K558 DELETION
Takuma Onoe
Favorite
Orbach, Daniel

SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, and University PSL, Paris, France
(P 393) EFFICACY AND SAFETY OF LAROTRECTINIB AS FIRST-LINE TREATMENT IN PATIENTS WITH TRK FUSION SARCOMAS
Daniel Orbach
Favorite
Organ, Bailey

Lunenefeld Tanenbaum
(P 433) TUMOR HYPOXIA AND THE RISK OF METASTASIS IN HIGH-RISK LOCALIZED UPS/MFS
Bailey Organ
Favorite
Oristian, Kristianne

Duke University
(P 301) GENOME-WIDE CRISPR/CAS9 VIABILITY SCREENS UNCOVER NOVEL GENETIC DEPENDENCIES IN CIC::DUX4 SARCOMA
Kristianne Oristian
Favorite
Orlando, Sarah

Fondazione Policlinico Campus Bio-Medico of Rome
(P 178) PREDICTION OF PRIMARY IMATINIB-REFRACTORY PATIENTS WITH LOCALLY ADVANCED OR METASTATIC GASTROINTESTINAL STROMAL TUMOR (GIST) USING RADIOMICS AND ARTIFICIAL INTELLIGENCE (AI)
Sarah Orlando
Favorite
OROSCO TTAMINA, Angel Luis

Clinical Research Facility, University College London NHS Foundation Trust
(P 23) METASTATIC ALVEOLAR SOFT PART SARCOMA: PREGNANCY-RELATED WORSENING AND SPONTANEOUS EXCEPTIONAL REMISSION POSTPARTUM- A CASE REPORT.
Angel Luis OROSCO TTAMINA
Favorite
Ortega, Luis

Hospital Clinico san Carlos
(P 208) PSYCOLOGICAL ASSESSMENT IN A SAMPLE OF PATIENTS AT HOSPITAL CLÍNICO SAN CARLOS (MADRID), SARCOMA NATIONAL REFERRAL CENTRE IN SPAIN. HIGHLIGTHING THE NEED OF A GLOBAL STANDARIZED PSYCHOLOGICAL APPROACH
Luis Ortega
Favorite
Osaki, Shuhei

National Cancer Center Hospital
(P 134) REAL-WORLD CLINICAL OUTCOME OF NEOADJUVANT CHEMOTHERAPY FOR RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Shuhei Osaki
Favorite
(P 249) TUMOR CELL DISAPPEARANCE FOLLOWING COVID-19 INFECTION IN A PATIENT WITH PLEOMORPHIC SPINDLE CELL SARCOMA: A CASE REPORT
Shuhei Osaki
Favorite
O'Sullivan-Coyne, Geraldine

Mater Misecordiae University Hospital (MMUH)
(P 413) SUSTAINED EFFICACY DURING DRUG HOLIDAY ON ATEZOLIZUMAB IN PATIENTS WITH ALVEOLAR SOFT PART SARCOMA (ASPS)
Geraldine O'Sullivan-Coyne
Favorite
Otero Norza, Diana

Hospital Dr. Rafael Angel Calderón Guardia
(P 367) AGE AS A PROGNOSTIC FACTOR IN RETROPERITONEAL SARCOMA: A MULTICENTER LATIN AMERICAN STUDY
Diana Otero Norza
Favorite
Outani, Hidetatsu

Osaka University
(P 324) BENZIMIDAZOLE DERIVATIVES AS NOVEL THERAPEUTIC AGENTS FOR INI1-DEFICIENT EPITHELIOID SARCOMA
Hidetatsu Outani
Favorite
(P 387) SUCCESSFUL PAZOPANIB TREATMENT OF UNDIFFERENTIATED PLEOMORPHIC SARCOMA WITH COAMPLIFICATION OF PDGFRA, VEGFR2, AND KIT: A CASE REPORT
Hidetatsu Outani
Favorite
Outilaft, Hassiba

iCube UMR 7357 - Laboratory for Engineering, Computer Science and Imaging- University Hospital of Strasbourg
(P 75) METABOLIC EVALUATION OF THE RELATIONSHIP BETWEEN MACROPHAGES AND OSTEOSARCOMA TUMOR CELLS
Hassiba Outilaft
Favorite
(P 89) TARGETED THERAPY OF MET, TYROSINE KINASE RECEPTOR, IN PEDIATRIC HIGH-GRADE OSTEOSARCOMAS : A NEW WAY TO TREAT PATIENTS ?
Hassiba Outilaft
Favorite
Oyama, Ryunosuke

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University
(P 203) IMPACT OF COVID-19 PANDEMIC ON BONE AND SOFT TISSUE SARCOMA PATIENTS' CONSULTATION AND DIAGNOSIS
Ryunosuke Oyama
Favorite
Oztosun, Gorkem

Washington University in St. Louis School of Medicine, Division of Oncology
(P 10) GENERATION OF A CHROMOSOME 8 GAIN;NF1-/- HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED SCHWANN CELL PRECURSOR MODEL
Gorkem Oztosun
Favorite
(P 335) FOCAL ADHESION KINASE (FAK) IS A THERPEUTIC TARGET IN CHROMOSOME 8 GAIN-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Gorkem Oztosun
Favorite